𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

✍ Scribed by Clozel, Martine; Breu, Volker; Burri, Kaspar; Cassal, Jean-Marie; Fischli, Walter; Gray, Gillian A.; Hirth, Georges; Löffier, Bernd-Michael; Müller, Marcel; Neidhart, Werner


Book ID
109786635
Publisher
Nature Publishing Group
Year
1993
Tongue
English
Weight
516 KB
Volume
365
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


ChemInform Abstract: Ethenesulfonamide D
✍ Hironori Harada; Jun-ichi Kazami; Susumu Watanuki; Ryuji Tsuzuki; Katsumi Sudoh; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Improvement of vascular endothelial func
✍ P. P. Sfikakis; C. Papamichael; K. S. Stamatelopoulos; D. Tousoulis; K. G. Fragi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objective Increased endothelin activity may play a role in the pathogenesis of vascular injury, a primary feature of systemic sclerosis (SSc; scleroderma). Our goal was to test the hypothesis that treatment with the oral endothelin receptor antagonist bosentan might improve vascular